Sahajanand Medical Technologies Limited announced that its wholly-owned subsidiary, Sahajanand Medical Technologies Ireland Limited, has approved an investment in SNP Medical Corp., a US-based medical device corporation. This strategic move aims to diversify the company’s product portfolio within its core business line. The acquisition is slated for completion by March 31, 2027, with an acquisition cost up to USD 7,80,000.
Strategic Investment in US Medical Device Sector
Sahajanand Medical Technologies Limited (SMT) has disclosed its Board of Directors’ approval for a significant investment by its wholly-owned subsidiary, Sahajanand Medical Technologies Ireland Limited, in SNP Medical Corp. This US-based corporation, registered in Delaware, operates within the medical device industry. The investment marks a strategic initiative to diversify SMT’s product portfolio, aligning with its existing main line of business.
Acquisition Details and Timeline
The transaction involves an investment in SNP Medical Corp., a medical device startup focused on developing innovative medical devices. The acquisition cost is capped at USD 7,80,000, with the final price per share to be determined based on SNP Medical Corporation’s valuation. As of September 30, 2026, SMT Ireland held a 14.15% stake in SNP Medical Corporation. This new acquisition is expected to increase that percentage to 17.19%. The tentative timeline for the completion of this acquisition is set for March 31, 2027.
Target Entity Background
SNP Medical Corp. is a Delaware-registered entity founded on May 31, 2022. The company’s reported revenue for recent years includes USD 3,00,000 for 2025, USD 2,34,960 for 2024, and USD 5,64,930 for 2023. It is important to note that Ms. Priyanka Cohen, a Promoter and Non-Executive Director of Sahajanand Medical Technologies Limited, also serves as a Director in SNP Medical Corp. The transaction has been conducted on an arm’s length basis.
Meeting Outcome
The Board of Directors of Sahajanand Medical Technologies Limited considered and approved this investment during their meeting held on November 05, 2026. The meeting commenced at 3:00 PM IST and concluded at 4:43 PM IST.
Source: BSE
